Fructose bisphosphatase deficiency is a single gene metabolic disorder in which the body has too little of the enzyme fructose bisphosphatase, so gluconeogenesis, the making of glucose from other molecules, cannot proceed correctly. Glycolysis, the breakdown of glucose, still works because it does not use this enzyme. Without effective gluconeogenesis, low blood sugar develops after roughly 12 hours of fasting, and fructose and glycerol cannot be used by the liver to maintain blood glucose. Acids can build up and lower the pH of the blood. Diagnosis rests on measuring the enzyme in cultured lymphocytes and confirming a mutation of the FBP1 gene. Treatment centers on avoiding long fasts and fructose containing foods and eating high carbohydrate food. The first known patient description appeared in The Lancet in 1970.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) First Described Sources
1. Fructose bisphosphatase deficiency (Wikipedia)
History
The first known description of a patient with this condition was published in 1970 in The Lancet journal.
Diagnosis
confirmed by detection of mutation of FBP1, encoding FDPase
lead sentence 1
In fructose bisphosphatase deficiency, there is not enough fructose bisphosphatase for gluconeogenesis to occur correctly.
Lead
In fructose bisphosphatase deficiency, there is not enough fructose bisphosphatase for gluconeogenesis to occur correctly.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.